Results 51 to 60 of about 22,435 (217)
A new diagnostic index for bacterial conjunctivitis in primary care. A re-derivation study [PDF]
Eighty per cent of primary care patients with infectious conjunctivitis are treated with antibiotics, although in only 30%, there is a bacterial cause.
van Weert, Henk C. P. M. +2 more
core +1 more source
Peptide‐based antibacterial nanoplatforms, encompassing self‐assembled peptides and peptide‐engineered inorganic, polymeric, and lipid nanocarriers, are systematically reviewed. The article highlights design principles and stimuli‐responsive regulation for improving peptide stability, delivery efficiency, and antibacterial performance.
Peng Tan +8 more
wiley +1 more source
BackgroundBacterial conjunctivitis is a significant cause of ocular morbidity globally, with increasing antimicrobial resistance posing a challenge to effective treatment.
Eyosias Teklemariam +6 more
doaj +1 more source
ABSTRACT Sargassum inundation of Caribbean and American shorelines is a growing environmental hazard. Hydrogen sulfide (H2S) and ammonia (NH3) produced by decomposing Sargassum could be involved in airway obstruction and bronchial inflammation. The study was undertaken to evaluate the effects of exposure to H2S and NH3 gases emitted during Sargassum ...
Rishika Banydeen +9 more
wiley +1 more source
Cellular Mechanism and Key Insights in Allergen Immunotherapy for Allergic Rhinitis
ABSTRACT Allergic rhinitis (AR) arises from immune responses mediated by immunoglobulin E (IgE) to inhaled allergens, representing one of the most prevalent chronic conditions worldwide. Although AR may not be a serious ailment, it holds clinical relevance as it underpins numerous complications, serves as a major risk factor for suboptimal asthma ...
Zhe Wang +3 more
wiley +1 more source
Eye disorders: bacterial conjunctivitis
Competing interests: None declared This article comes from Clinical Evidence (2000;3:305-310), a new resource for clinicians produced jointly by the BMJ Publishing Group and the American College of Physicians—American Society of Internal Medicine.
C W, Chung, E J, Cohen
openaire +3 more sources
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes [PDF]
Timothy W Morris1, Lynne S Gearinger1, Dale W Usner2, Michael R Paterno2, Heleen H DeCory3, Timothy L Comstock3, Wolfgang Haas11Microbiology and Sterilization Sciences, 2Clinical Affairs, 3Global Pharmaceutical Medical Affairs, Bausch & Lomb ...
DeCory HH +6 more
core
Bacterial flora in acute conjunctivitis
Agarwala H, Raichaudhury M, Munsi N
doaj +2 more sources
Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery +25 more
wiley +1 more source
Bacterial conjunctivitis [PDF]
Konjunktivitis je upala spojnice i jedan od najčeščih entiteta s kojima se liječnik može susresti u kliničkoj praksi. Bakterijski konjunktivitis uzrokovan je različitim spektrom uzročnika. Spojnica posjeduje obrambene mehanizme koji je štite od infekcije
Žibrat, Zlatko
core

